Estrovera Reviews: Does It Work for Hot Flashes?

Estrovera reviews on Metagenics' site are mostly positive, and its ERr 731 extract beat placebo in small 12-week trials, but the evidence has important limits. The Menopause Society doesn't recommend it for hot flashes. Before buying, weigh the safety warnings, full order cost and 60-day refund window.

If you're considering Estrovera:

• Discuss with your clinician whether a supplement fits your health history before you buy
• Know that "hormone-free" isn't the same as "no estrogen-like activity" (we explain below)
• If you choose it, keep a simple symptom log to record changes and questions for follow-up; a log cannot prove what caused a change

Talk to a clinician first, or skip it, if you:

• Have had breast cancer or another hormone-sensitive cancer. The extract acts on an estrogen receptor, and it hasn't been studied in survivors.
• Are pregnant or nursing, have frequent diarrhea or stomach pain, or take other medicines. Those are on the label.
• Have hot flashes that are wrecking your sleep, work or mood. That deserves treatment with stronger proof.
• Have had any bleeding after menopause. That needs a doctor's check first, whatever you take.

We don't earn anything from Estrovera or Metagenics. We may earn a commission if you start care with Gala Health through our links. That doesn't change what we report. How we make money.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What we actually verified · Last verified October 2026

Our October 16, 2026 source check covers: Metagenics' HerWellness Estrovera label, directions, warnings, prices, displayed review summary and selected reviews; its guarantee, shipping and HSA/FSA terms; The Menopause Society's 2023 statement; the published ERr 731 trials and follow-ups; a 2024 meta-analysis; the FDA's dietary supplement Q&A; and Gala's HRT offer, hormone-health pages, general terms and refund policy.

We confirmed from the label and offer: each tablet lists 4 mg of ERr 731. The label says one tablet a day with food. Metagenics listed $39.95 for 30 tablets, $95.88 per three-bottle subscription shipment ($31.96 per 30-tablet bottle), and $104.95 for 90 tablets bought once. Refund requests must come within 60 days of purchase and require approval.

We did not: buy, take or test Estrovera, or contact Metagenics. This is a review of documents and published research, not a personal trial.

We could not confirm: which "6 clinical studies" Metagenics counts, whether a particular Amazon seller is authorized, or Gala's exact medicine coverage, required lab costs and HRT billing interval. The written Metagenics guarantee does not list a subscription exclusion.

On this page: What reviews say · Does it work? · What The Menopause Society said · Hormone-free? · Safety · Cost and refund · 12-week plan · Who it fits · Better-proven options · When to see a clinician · Gala · Lookalikes · Quick answers

---

What do Estrovera reviews actually say? {#reviews}

On Metagenics' own website, Estrovera has an average of 4.2 out of 5 stars from 157 reviews, and 83% of reviewers say they'd recommend it (recorded October 16, 2026). Positive reviews in our sample describe fewer hot flashes and night sweats and better sleep within a few weeks. Negative examples describe no benefit or trouble with an order.

Here's how those 157 ratings break down.

Estrovera ratings on Metagenics.com (recorded October 16, 2026)

Stars	Number of reviews	Share of total
5 stars	108	69%
4 stars	14	9%
3 stars	11	7%
2 stars	7	4%
1 star	17	11%
Total	157	100% (rounded)

Shares are our math from Metagenics' published counts. These are reviews hosted by the seller.

Seller-hosted reviews are still useful. They just answer a different question than the one you probably care most about. They tell you how buying and taking Estrovera felt to the people who chose to write in. They can't tell you whether it's safe with your health history, or whether it beat a placebo.

The patterns we saw

We examined selected recent reviews and the "most liked" positive and negative ones. Four themes stood out.

"It calmed my hot flashes." In the reviews we examined, women describe fewer or milder hot flashes, fewer night sweats and better sleep. Several say they've taken it for years.

"I can't take hormones." Some reviewers chose Estrovera because hormone therapy wasn't an option for them, or because they didn't want it. One reviewer labeled a verified buyer by the seller, from Tennessee, put it simply: "I'm unable to take hormones so this was a great alternative." Another buyer with that label, from California, said she felt better after about two weeks, with steadier body temperature and better sleep.

"It helped, but not enough." The most-liked positive review is a 4-star one. The reviewer said Estrovera helped her intense nighttime heat years ago. When she came back to it later, it helped again, but she still couldn't give up her estradiol patch. That's an honest picture of a modest effect.

"Nothing changed," or "my order didn't." The 1-star reviews mix "didn't work for me" with service problems. The most-liked negative review wasn't about the tablet at all. It was about a missing package and a slow refund.

These are individual reports on the seller's site. They aren't typical results, and they aren't medical proof.

What other review sites show

Consumer Health Digest lists Estrovera at 3.8 out of 5 from 17 reader reviews (page dated April 2025). Read it with care. That page says no money-back guarantee is offered, but Metagenics does offer one, and it lists an older price. It also promotes other menopause supplements it earns money from.

Why star ratings can't settle this

Ratings answer, "Did people like it?" Your real questions are probably, "Will it work for me, and is it safe for me?" For those, you need the studies, what menopause experts concluded about them, and your own health history. That's next.

---

Does Estrovera work for hot flashes? {#evidence}

Estrovera's ingredient, ERr 731, improved menopause symptom scores more than a placebo in two small 12-week trials of women in perimenopause — the years leading up to menopause. Most of the research was funded or run by the extract's German maker, and the main trial lost most of its placebo group. So the honest answer is "it helped in studies, but the proof is weak."

What Estrovera actually is

Estrovera is a once-a-day tablet sold by Metagenics, now under the name HerWellness Estrovera. It contains one active ingredient: ERr 731, a standardized extract from the root of rhapontic rhubarb (Rheum rhaponticum), also called Siberian rhubarb. It's not the rhubarb in pie.

Each tablet holds 4 mg of ERr 731, which provides 2.2 mg of rhaponticin and 1 mg of desoxy-rhaponticin. Those are the two plant compounds the extract is standardized to. It has been used in Germany since 1993, originally marketed as Phytoestrol N; the later names include Phyto-Strol and Phyto-Strol Loges (original 2009 study).

How the studies measured symptoms

Most ERr 731 studies used the Menopause Rating Scale (MRS). It's an 11-item checklist where women rate symptoms such as hot flashes, sleep problems, mood, anxiety, joint aches and vaginal dryness from 0 (none) to 4 (very severe). A lower score means fewer or milder symptoms.

That matters for one reason. Most results are for the total score, not hot flashes alone. A drop in the total can come from better sleep or mood, not only fewer hot flashes.

The main trial

The study Metagenics leans on most was published in the journal Menopause in 2006 (Heger and colleagues). Here's what it was, from the Cochrane review's study table (Cochrane, 2013) and The Menopause Society's summary.

• Who: women aged 45 to 55 in perimenopause with moderate-to-severe symptoms, at nine outpatient clinics in Ukraine, 2003 to 2004
• What: one ERr 731 tablet a day or a placebo, for 12 weeks
• Result: the ERr 731 group's symptom scores improved much more than placebo, including hot flashes
• Who paid: the German company that makes the extract, plus a research firm working with it
• The big problem: only 7 of 55 women on placebo finished the trial, compared with 39 of 54 on ERr 731

That last point is the one experts flagged. The high, uneven dropout rate makes the benefit estimate less certain. The analysis carried earlier recorded scores forward when later scores were missing, so it was not simply a comparison of the women who finished.

A second 12-week randomized, placebo-controlled trial enrolled 112 perimenopausal women at gynecology clinics in Ukraine and was published in 2009. It also reported lower symptom scores and fewer hot flashes with ERr 731 than with placebo (Kaszkin-Bettag et al., 2009).

What longer and larger studies add

Long-term follow-up. Eighty women entered the first 48-week extension, and 51 entered the second. Both original groups received ERr 731 during follow-up, so there was no continuing placebo comparison. Symptoms stayed low, and the study reported no treatment-related adverse events (PubMed 18978638). These small, uncontrolled studies cannot rule out uncommon or long-term harms.

A 6-month German practice study. Doctors at 70 gynecology practices gave ERr 731 to 363 women. Among the 252 analyzed, the average MRS score fell from 14.5 to 6.5 over six months (PubMed 19043936). There was no placebo group, so some of that drop could be time passing, expectation, or women who weren't helped dropping out.

A 2024 meta-analysis. A meta-analysis pools study results. This one combined four reports and found a 15.12-point difference in total MRS scores favoring ERr 731 (Dubey et al., 2024). But these were not four independent trials in 390 different women: the reports overlap, including a follow-up of women from the original trial. Results also varied greatly between reports (I² 93%). One statistical test suggested publication bias — positive results being more likely to appear in print — while another did not. The analysis did not pool individual symptoms. The authors work for a supplement company and reported no funding or conflicts. The pooled number should not be treated as a reliable prediction of one woman's benefit.

What this means in real life

Picture a woman with eight hot flashes a day. A change in a total symptom score cannot tell her how many of those eight will remain. She might report fewer or milder flashes, or no change. The trials don't let anyone predict her result.

That's exactly why a symptom log is useful alongside the research. Your own numbers will show what happened to you, though they cannot prove the supplement caused a change. Bring them to your clinician.

The Estrovera Claim Check

Here are the main claims on Estrovera's page, where they come from, and what they really mean. We checked their wording and cited support on October 16, 2026.

What you'll see	Where it comes from	Who ran or paid for it	What it means for you
"Relieves 12 symptoms by up to 83%"	Metagenics' footnote describes mean reductions in individual MRS scores compared with placebo	ERr 731 trials, mostly maker-funded	This is a symptom-score claim, not a finding that 83% of women got relief or that every symptom improved by 83%. The footnote does not make the exact calculation clear.
"90% of women surveyed noticed improvements in hot flashes"	Online survey, March 2023, of 424 women currently or previously taking Estrovera	Metagenics	These are buyers who chose the product and answered the company's survey. There's no comparison group. Read it as "buyers liked it."
"83% of women reported symptom relief in as little as 1–4 weeks"	Main sales bullet links this to an online survey, Sept. 21–Oct. 5, 2020, of 75 current users	Metagenics	Small, current users only. Some repeated page text swaps the survey footnote symbols, so the page's attribution is inconsistent. Neither survey is a placebo-controlled trial.
"#1 OBGYN-recommended ingredient"	Research by IQVIA conducted for Metagenics	Paid for by Metagenics	The product page does not give the method. Treat it as marketing.
"Hormone-free"	Product page	Metagenics	True: the tablet contains no hormones. But lab studies show it acts on an estrogen receptor. See the next section.
"Backed by 6 clinical studies"	Product page	Exact six not identified; much of the identifiable research is linked to the maker	We found two 12-week placebo trials, follow-ups, open studies and a 2024 meta-analysis of overlapping reports. We could not identify the exact six from the page and detail aid.
"Safe for long-term use"	Product page; follow-up studies	Researchers linked to the maker	The follow-up reported no treatment-related adverse events, but it was small and had no continuing placebo group. It does not establish safety in cancer survivors.
"Clinically proven"	Product page	Metagenics	Two small, short, maker-funded trials. The Menopause Society called the conclusions limited and doesn't recommend it.
The Menopause Society's view	2023 Nonhormone Therapy Position Statement	Independent expert panel	Reviewed Estrovera by name. Not recommended. Details below.

Our read: ERr 731 has human trial data, but the studies have important limits. The placebo-controlled trials are small, short, mostly paid for by the maker and hard to interpret because of the dropouts. Guideline-recommended options have stronger support for treating hot flashes.

---

What did The Menopause Society say about Estrovera? {#menopause-society}

The Menopause Society's 2023 Nonhormone Therapy Position Statement reviewed Estrovera by name and rated it "not recommended" for hot flashes. The experts said the main trial's very low placebo retention and the open-label design of another study limit what anyone can conclude.

The Menopause Society, formerly The North American Menopause Society, is a U.S. professional group for menopause care. Its 2023 statement reviewed evidence for non-hormone treatments for hot flashes and night sweats. Hot flashes and night sweats are called vasomotor symptoms, or VMS. The statement sorted treatments into "recommended" and "not recommended" (The Menopause Society, Menopause 2023).

In its section on herbal treatments, the panel discussed Siberian rhubarb and named Estrovera as the U.S. product. It described the extract as one that "contains estrogenic properties but is not estrogen." Then it pointed to the numbers we covered above: only 7 of 55 placebo patients finished the main trial, the long-term safety group was small, and a later study in India had no placebo group. Because of that, it rated the evidence Level II and put Estrovera on the not recommended list.

Here's a summary of that list.

The Menopause Society's 2023 nonhormone recommendations for hot flashes

Recommended	Evidence level	Not recommended (examples)
Cognitive-behavioral therapy (CBT)	Level I	Supplements and herbal remedies, including Estrovera (rhubarb extract)
Clinical hypnosis	Level I	Paced breathing
SSRIs and SNRIs (certain antidepressant medicines)	Level I	Soy foods, soy extracts and the soy compound equol
Gabapentin	Level I	Cannabinoids
Fezolinetant (Veozah)	Level I	Acupuncture
Oxybutynin	Levels I–II	Exercise, yoga and cooling techniques as hot flash treatments
Weight loss; stellate ganglion block (a nerve injection)	Levels II–III	Clonidine; pregabalin; chiropractic care

Source: The Menopause Society, The 2023 Nonhormone Therapy Position Statement, Menopause 2023;30(6):573–590. Level I means the strongest evidence, from good randomized trials.

The statement also says hormone therapy remains the most effective treatment for hot flashes. For healthy symptomatic women younger than 60 or within 10 years of menopause, the benefit-risk balance is generally favorable when there is no contraindication — a health reason not to use it. A clinician still needs to review the individual situation.

"Not recommended" doesn't mean "dangerous." It means the experts didn't find strong enough proof that it works to point women toward it. You're allowed to ask about it anyway. Just go in knowing the limits and discuss whether it fits your health history.

Not sure whether a supplement is enough for what you're dealing with? The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

It's free, takes about 60 seconds, asks five questions and doesn't ask for your email. Your answers stay in your browser. It doesn't diagnose anything or decide whether you should take hormones. A clinician does that. We may earn a commission from the providers it features, and that affects which ones appear. You can read exactly how Find My HRT Path works.

---

Is Estrovera hormone-free, or does it act like estrogen? {#hormone-free}

Estrovera contains no hormones, and Metagenics says it doesn't change your estrogen levels. But lab studies show its rhubarb compounds switch on estrogen receptor beta, one of the body's two main estrogen "docking spots." So "hormone-free" doesn't mean it has no estrogen-related activity at all.

A quick, plain explanation

Estrogen works by plugging into estrogen receptors on your cells, like a key in a lock. There are two main types: alpha (ERα) and beta (ERβ). They're spread differently around the body and do somewhat different jobs.

In lab tests, ERr 731 and its compounds turned on the beta receptor. They didn't turn on the alpha receptor in most of the systems tested, with only a very weak alpha signal in one bone-cell test (Wober et al., 2007; Vollmer et al., 2010). In a rat study, it didn't make the uterus grow the way estradiol does. That's encouraging for the uterine lining, but rats aren't people.

Plant compounds that act on estrogen receptors are called phytoestrogens. That's the camp ERr 731 falls into, even though it isn't soy and isn't a hormone. For a wider look at that category, see our guide to phytoestrogens for menopause.

The mixed message from Metagenics

Metagenics explains this two different ways.

• Its consumer product page says ERr 731 works through the body's serotonin pathways instead of hormone pathways.
• Its clinician detail aid describes ERr 731 as a phytoestrogen that prefers the estrogen beta receptor.
• The Menopause Society says it has estrogenic properties but isn't estrogen.

The consumer wording does not erase the receptor findings. If you were told "hormone-free" and heard "nothing estrogen-like," that's not the full picture.

Why this matters to you

It matters especially if you've had breast cancer or another hormone-sensitive cancer, take a medicine that blocks estrogen, or have been told to avoid estrogen. Then the question isn't "does it contain hormones?" It's "does it act on estrogen receptors, and is that okay for me?" That's a question for your oncologist or doctor, and it's covered in the safety section.

---

MY ESTROVERA TRIAL (private)

Bought on: __________   Where: Metagenics / authorized seller / other (check the guarantee)
Started on: __________
Early refund reminder (purchase date + 56 days): __________
60-day policy date (purchase date + 60 days): __________
Exact seller-confirmed request deadline: __________
Week 4 check: __________   Week 8 symptom check: __________   Week 12 check: __________

BEFORE I START (average of 3 days)
Hot flashes per day: ____   Night sweats or wake-ups per night: ____   Sleep quality (1–5): ____
For sleep: 1 = very poor, 5 = very good. This is your own rating, not a medical score.

Week | Hot flashes/day (avg) | Night wake-ups | Sleep 1–5 | Stomach or other side effects
  1  |                       |                |           |
  2  |                       |                |           |
  3  |                       |                |           |
  4  |                       |                |           |   <- week 4 check
  5  |                       |                |           |
  6  |                       |                |           |
  7  |                       |                |           |
  8  |                       |                |           |   <- symptom check; use purchase-based refund dates above
  9  |                       |                |           |
 10  |                       |                |           |
 11  |                       |                |           |
 12  |                       |                |           |   <- week 12 check

Bring this log to your clinician. Call a doctor promptly for: any bleeding after
menopause, ongoing diarrhea, or severe stomach pain.

Who should try Estrovera, and who should skip it? {#fit}

Some women prefer a supplement before prescription care, but the research does not identify milder hot flashes as a group that responds better to Estrovera. Discuss medical fit first, especially with severe symptoms, a hormone-sensitive cancer history, unexplained bleeding, stomach problems or regular medicines.

Find yourself in this table.

Your situation	Does Estrovera fit?	Why	Best next step
Want to avoid hormones and prefer a supplement before prescription care	A choice to discuss with your clinician	Some trial support, but not a guideline recommendation; refund conditions limit what the guarantee covers	Resolve health questions first; if you choose it, use the log and purchase-based refund reminder
In perimenopause (the transition before menopause; periods may become irregular)	Possibly, after a health review	The main trials were done in perimenopausal women	Ask whether it fits your history and medicines
Postmenopause (12+ months with no period)	Less studied	The main trials enrolled perimenopausal women	Ask your clinician; consider better-proven options
Hot flashes that wreck sleep, work or mood	Probably not your first choice	Stronger-evidence options exist	Find My HRT Path or a clinician
Breast or other hormone-sensitive cancer history	Ask your oncologist first	Acts on an estrogen receptor; not studied in survivors	Oncologist; non-hormonal options
Already tried Estrovera 8–12 weeks with little change	Time for a clinician review	Persistent symptoms deserve attention; your log describes what happened	Gala if its cash-pay care fits, or Find My HRT Path if you're unsure
Main problem is vaginal dryness or pain with sex	Not the best tool	Local treatments target this directly	Vaginal estrogen guide
Already on HRT and want to add it	Ask your prescriber	We found no studies of the combination	Your prescriber
Pregnant, nursing, frequent diarrhea or stomach pain	No	Label warnings	Your clinician
Bleeding after menopause	Not until checked	Needs an exam	In-person care

The one limitation that matters most

The main limits are uncertain benefit and incomplete safety evidence. Buying enough tablets for eight weeks costs $89.90 for two small bottles bought together with standard shipping, or $95.88 for the displayed three-bottle subscription, before tax. If your symptoms are severe, eight weeks can also mean two more months of broken sleep. That's when going straight to a clinician makes more sense.

---

Which hot flash treatments have stronger evidence than Estrovera? {#alternatives}

Hormone therapy is the most effective treatment for hot flashes. Several prescription non-hormone options, including fezolinetant (Veozah), certain antidepressants such as low-dose paroxetine, gabapentin and oxybutynin, are recommended by The Menopause Society. Which one fits depends on your health history, so a clinician should help you choose.

Here's how the main choices compare. We've kept to what we could verify.

Hot flash options compared (checked October 2026)

Option	What it is	FDA status for hot flashes	Menopause Society 2023	Prescription?	Cost we verified	Watch-outs
Estrovera	ERr 731 rhubarb extract	Not FDA-approved (supplement)	Not recommended	No	$39.95/30 buy once; displayed subscription $95.88 per 90 tablets, before tax	Weak evidence; stomach warning; not studied in cancer survivors
Hormone therapy (estradiol pill or patch, generally with a progestogen if you have a uterus)	Replaces estrogen	Many FDA-approved products	Most effective treatment	Yes	Varies; Gala advertises a $69/month HRT plan. Exact medicine coverage and any required labs need confirmation.	Not right for some histories; women with a uterus need uterine protection
Fezolinetant (Veozah)	Blocks a brain signal (NK3) that triggers hot flashes	FDA-approved	Recommended (Level I)	Yes	Not verified here	Boxed warning for rare serious liver injury; liver blood tests before starting, monthly for 3 months, then at months 6 and 9
Elinzanetant (Lynkuet)	Blocks two brain signals (NK1 and NK3)	FDA-approved October 24, 2025	Approved after the 2023 statement	Yes	Not verified here	Seizure risk, daytime sleepiness and liver-enzyme rises; liver tests before treatment and at 3 months; contraindicated in pregnancy
Paroxetine 7.5 mg (Brisdelle)	Very low-dose antidepressant	FDA-approved for hot flashes	Recommended (SSRIs, Level I)	Yes	See paroxetine for hot flashes	Drug interactions; ask about every medicine you take
Other SSRIs and SNRIs (escitalopram, venlafaxine and others)	Antidepressant medicines	Off-label for hot flashes	Recommended (Level I)	Yes	Varies	Side effects and interactions
Gabapentin	Nerve-pain and seizure medicine	Off-label	Recommended (Level I)	Yes	Varies	Sleepiness; often used at night
Oxybutynin	Bladder medicine	Off-label	Recommended (Levels I–II)	Yes	See oxybutynin for hot flashes	Side effects, especially in older women
CBT or clinical hypnosis	Structured skills programs	Not a drug	Recommended (Level I)	No	Varies	Often eases how much hot flashes bother you

Off-label means a medicine is FDA-approved for something else and prescribed for hot flashes by a clinician. Veozah and Lynkuet are approved for moderate-to-severe hot flashes due to menopause. Their details were checked against the current Veozah label and Lynkuet label. This is a comparison of evidence and options, not a claim that each medicine beat Estrovera head to head. For costs, see oxybutynin vs. Veozah.

Two terms worth knowing

Systemic vs. local. Pills and patches that treat hot flashes are systemic: they travel through your whole body. Low-dose vaginal estrogen is local: it mostly stays where it's applied. It helps dryness and some urinary symptoms, but it won't fix hot flashes.

Uterine protection. A progestogen is progesterone or a medicine with similar effects. If you still have a uterus and take systemic estradiol, a clinician generally also prescribes a progestogen to protect the uterine lining. That's a clinician's job to plan, and it's one more reason hormone therapy should come with real medical oversight.

What about the 2026 label changes?

On February 12, 2026, the FDA approved labeling changes for six menopausal hormone therapy products that removed some boxed-warning language. That doesn't make hormones right or risk-free for everyone. It does mean some old fears are worth a fresh conversation with a clinician. Our 2026 label changes explainer has the details.

---

When should you skip supplements and see a clinician? {#clinician}

See a clinician first if hot flashes or night sweats disrupt your sleep, work or mood; if you've already tried a supplement for 8 to 12 weeks without clear change; if you have any bleeding after menopause; or if you have a cancer, blood clot, stroke, heart or liver history. Those situations need someone who can review your full history.

Here's a quick self-check. Tick any that are true.

• ☐ I wake up from night sweats most nights.
• ☐ I've already tried a supplement, including Estrovera, for at least 8 weeks.
• ☐ My symptoms are affecting my work, relationships or mood.
• ☐ I've had bleeding after menopause, or bleeding no one has explained.
• ☐ I've had breast cancer, a blood clot, a stroke, heart disease or liver disease.

One or more of the first three? You'd likely get more from one clinician conversation than another bottle.

Either of the last two? Please start with an in-person clinician. Online care and supplements aren't the right first step for those.

If you'd like to talk to a specialist face to face, The Menopause Society keeps a public directory of menopause practitioners, including participating Society members and certified practitioners. If you're weighing hormone therapy itself, our guide to HRT for hot flashes walks through how it works.

---

Is Gala Health a good next step if Estrovera isn't enough? {#gala}

Gala Health may fit cash-paying readers who want an online clinician to review menopause symptoms. Its dedicated HRT page advertises $69 a month, including clinician review, medication and shipping. Gala separately lists non-hormonal options, including fezolinetant, but their price and required lab costs remain unconfirmed.

Why Gala fits many women who land here

You want stronger evidence, but still want to avoid hormones. Gala's non-hormonal page lists fezolinetant (checked October 16, 2026), an FDA-approved medicine recommended by The Menopause Society for hot flashes. Ask whether Gala offers it for your situation and what the medicine and liver tests would cost. If you have a hormone-sensitive cancer history, your oncologist should weigh in first.

You're open to hormones after all. Gala lists an estradiol pill or patch, progesterone and vaginal estradiol, with a clinician deciding what fits (hormone-health page, October 16, 2026).

You want one simple monthly price. Gala's dedicated HRT offer advertises $69 a month and says that price covers clinician review, medication and shipping, with no separate membership fee. Gala does not bill insurance and says it accepts HSA and FSA cards. Confirm the exact medicine, amount due now and billing interval before paying.

You want ongoing help, not a one-time script. Gala says provider messaging, symptom check-ins and dose changes are included for as long as you're treated.

What to know before you start

We reviewed Gala's documents in depth in our Gala Health HRT review. The short version:

• The exact medicine isn't named up front. Gala says it prescribes FDA-approved forms, but one of its landing pages carries a general compounded-medication notice. Ask which product you'd get.
• Non-hormone drug pricing wasn't shown on the pages we read. We couldn't confirm whether fezolinetant is inside the $69 plan, or who arranges and pays for its required liver blood tests.
• Cancelling has a deadline. Gala's general refund policy requires a cancellation request at least 72 hours before the billing date. Missing that cutoff can lead to another charge. Confirm the policy and cancellation method that apply to your HRT plan, including refunds and how long refills remain available.
• Access depends on your situation. Gala says it serves most U.S. states, but we could not confirm a complete HRT state list or age limits. Ask whether its care is available for your age and state before paying.
• No insurance billing. If you have a strong PPO plan, a covered route may cost less.
• Reviews mix programs. Gala's big Trustpilot score covers all its services, including weight loss, so it isn't an HRT-only rating.

Three questions to send Gala before you pay:

1. "Which exact medicine would I receive, and is it an FDA-approved product?"
2. "Is it included in the $69, and are any lab tests extra?"
3. "How much is due now, how often will I be charged, is there a minimum term, and how do cancellation, refunds and remaining refills work?"

If you're ready to move past supplements and Gala's setup fits you, you can start its online assessment now and keep this page open for the questions.

Gala may pay The HRT Index if you enroll. A prescription is never guaranteed. A licensed clinician decides what's right for you.

If Gala isn't the right fit

• You want insurance to pay: an in-network option such as Midi Health may cost less; coverage depends on your state and plan. See Gala vs. Midi.
• You need a specific FDA-approved product named before you pay: start with a provider that publishes its product menu. See our comparison of online HRT providers.
• You have a cancer history: your oncologist first, then a clinician who can coordinate with them.
• You'd rather start with your own doctor: that's always a good choice. Bring your symptom log.

---

Estrovera vs. Estroven, Life Extension and other lookalikes {#lookalikes}

Estrovera isn't the only product using ERr 731: Estroven Complete Multi-Symptom Menopause Relief also identifies that extract. Life Extension's current Menopause Relief page lists 4 mg of standardized Siberian rhubarb, but does not name ERr 731. Other formulas can use different ingredients, so reviews of one don't automatically carry over to another.

The names are easy to mix up on a store shelf, so here's a clear table.

Rhubarb-extract and similar menopause supplements (manufacturer information checked October 16, 2026)

Product	Ingredient listed	Branded extract / amount confirmation	Cancer caution on manufacturer page	Note
HerWellness Estrovera (Metagenics)	ERr 731, 4 mg	Named on current label	None on U.S. label	60-day guarantee, subject to its terms
Estroven Complete Multi-Symptom Menopause Relief (i-Health)	Rhapontic rhubarb; ERr 731	Manufacturer FAQ names ERr 731; 4 mg in the retailer label capture	Not identified in the text reviewed	Different company; check the current bottle label and its own return policy
Life Extension Menopause Relief (formerly listed as Menopause 731)	Standardized Siberian rhubarb extract, 4 mg	Current manufacturer page does not name ERr 731	Consult a healthcare practitioner for current or previous estrogen-dependent tumors	The missing trademark does not prove the extract changed
Other Estroven formulas	Depends on the exact product	Do not assume ERr 731	Check the exact label	Different ingredients and evidence

Labels change. Check the Supplement Facts panel on the bottle you're buying.

How to use this: research on ERr 731 at 4 mg is relevant when a product contains that extract at the studied amount. That does not prove every finished product has been tested or that different brands are interchangeable. Check the current label, other ingredients, quality information and warnings. If it lists soy, black cohosh or other herbs instead, the ERr 731 research doesn't apply. The Menopause Society doesn't recommend soy or herbal supplements for hot flashes either.

There's no "generic Estrovera" in the drug sense, because it isn't a drug. Same-extract products are simply other brands. Compare price, return policy and label cautions.

---

How we reviewed Estrovera {#method}

We read Metagenics' current product, label and guarantee pages, the published ERr 731 studies, The Menopause Society's 2023 statement and the FDA's supplement rules, then checked each claim against its source. We didn't buy or take Estrovera, and we don't give it a score.

For this review, we use The HRT Index Verification Standard and five decision pillars. Here's how they apply to a supplement.

Pillar	What we looked for	What we found for Estrovera	Status
1. Clinical legitimacy	Is it what it says? Who studied it?	A dietary supplement, not FDA-approved. Quality testing and GMP manufacturing claimed. Studies small and mostly linked to the maker. The Menopause Society reviewed it by name: not recommended.	Confirmed from sources
2. Care quality	Guidance, support and how problems are handled	A retail purchase does not include a menopause-care consultation. Some reviewers report delivery and refund problems.	Documents and reviews only
3. Medication fit	Ingredient, amount, cautions, who it suits	4 mg ERr 731 daily. Acts on estrogen receptor beta. Not studied in cancer survivors. Label warns about pregnancy, nursing, medicines and diarrhea.	Confirmed (label); evidence limited
4. Price transparency	Prices, subscription terms, refunds	Full subscription order and general shipping costs identified. 60-day guarantee from purchase, with approval required; no subscription exclusion listed.	Documents checked; tax/destination extras vary
5. Access	Where and how you can get it	Sold without a prescription; confirm shipping to your location. HSA/FSA checkout requires approval and excludes subscriptions. Guarantee covers direct or authorized-seller purchases.	Manufacturer terms checked

What would change our view: a new independent placebo-controlled trial, especially in the U.S. or in postmenopausal women; a Menopause Society update; studies in breast cancer survivors; or changes to Metagenics' price or guarantee.

Our full approach is on our methodology page. We don't earn money from Estrovera. We do earn commissions from some providers, including Gala, and we say so wherever those links appear.

---

Bottom line: should you try Estrovera? {#bottom-line}

Estrovera has some trial support, but it isn't a guideline-recommended treatment for hot flashes. If you prefer a supplement, discuss whether it fits your health history, then keep a log if you choose it. Use purchase-based refund dates. If symptoms are severe, it hasn't helped, or you have a cancer history, start with a clinician.

The whole page in four lines:

• The reviews: mostly positive on the seller's site (4.2 out of 5 from 157 reviews), with "it didn't help" among the complaints in our sample.
• The evidence: two small, maker-funded 12-week trials showed benefit, but The Menopause Society reviewed Estrovera by name and doesn't recommend it.
• The cost: $95.88 to $119.85 before tax to buy 90 tablets up front under the compared options; separate small-bottle orders add shipping. Refund requests must be within 60 days of purchase and require approval.
• The next step: resolve medical fit, use a log if you choose the supplement, or ask about treatments with stronger evidence.

If you've resolved the health questions and are ready to try it, buy from Metagenics or an authorized seller, keep your receipt and use the log and refund reminder above. See Estrovera on Metagenics → (not an affiliate link)

If you're still not sure whether a supplement, hormones or a non-hormone prescription is right for you, take the free matching quiz. It asks five questions about your symptoms, what you've tried, your age, your state and your health history. Then it shows a featured online care option, or tells you when online care isn't the right place to start. About 60 seconds, no email.

Already know you want a clinician to look at prescription options? You can go straight to Gala's online assessment.

And if you already have a doctor who knows your history, it's always fair to ask them first. Bring your log.

---